PDCD1 and non-small cell lung carcinoma: False positive results have also been reported with [18F]FLT; e.g., this occurred due to pseudoprogression two weeks after anti-PD-1 therapy in 26 patients with advanced non-small cell lung cancer (NSCLC) [17].